Changes in the total number of shares and votes in Arcam
After the completion of the rights issue, the number of shares and votes in Arcam Aktiebolag (publ) ("Arcam") increased by 4,109,286 in November 2017.
Arcam announced by press release on November 16, 2017 that the rights issue, for which the subscription period ended on November 9, 2017, was fully subscribed and 4,109,286 new ordinary shares were issued. Today, the last trading day of the month, the total number of shares and votes in Arcam amounts to 24,855,871, where 24,655,871 comprise of ordinary shares and 200,000 comprise of preference shares of series C. Following the rights issue, the share capital increased by approximately SEK 4,109,286 and amounts to SEK 24,855,873.
This information is information that Arcam Aktiebolag (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out below on November 30, 2017, at 8:00 a.m. CET.
For further information:
Magnus René, CEO and President, Arcam
Cell: +46 702 79 89 99 or +1 781 266 6957
Arcam brings together best-in-class additive manufacturing systems, the highest quality materials, and real-world production expertise, changing the way manufacturers conceive and produce metal components. Together we use our collective knowledge to inspire and disrupt conventional thinking. Through our solution orientation, Arcam is an innovative partner for advanced manufacturing, primarily in the aerospace and medical industries.
Arcam provides Electron Beam Melting systems through Arcam EBM in Sweden, powder metals through AP&C in Canada and implant contract manufacturing through DTI in the U.S. Arcam AB has headquarter functions based in Sweden and in the U.S. and is listed on Nasdaq Stockholm.
Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden